{"abstract": "Though AbbVie, based in Chicago, stopped short of raising its $46 billion takeover offer, its presentation and investor call on Wednesday made the case for a deal with Shire.", "web_url": "https://dealbook.nytimes.com/2014/06/25/abbvie-signals-it-will-continue-to-pursue-irish-drug-maker-shire/", "snippet": "Though AbbVie, based in Chicago, stopped short of raising its $46 billion takeover offer, its presentation and investor call on Wednesday made the case for a deal with Shire.", "lead_paragraph": "Updated, 2:28 p.m. | ", "print_section": "B", "print_page": "4", "source": "The New York Times", "multimedia": [{"rank": 0, "subtype": "xlarge", "caption": null, "credit": null, "type": "image", "url": "images/2014/06/26/business/dbpix-shire/dbpix-shire-articleLarge.jpg", "height": 419, "width": 600, "subType": "xlarge", "crop_name": "articleLarge", "legacy": {"xlarge": "images/2014/06/26/business/dbpix-shire/dbpix-shire-articleLarge.jpg", "xlargewidth": 600, "xlargeheight": 419}}, {"rank": 0, "subtype": "jumbo", "caption": null, "credit": null, "type": "image", "url": "images/2014/06/26/business/dbpix-shire/dbpix-shire-jumbo.jpg", "height": 419, "width": 600, "subType": "jumbo", "crop_name": "jumbo", "legacy": {}}, {"rank": 0, "subtype": "superJumbo", "caption": null, "credit": null, "type": "image", "url": "images/2014/06/26/business/dbpix-shire/dbpix-shire-superJumbo.jpg", "height": 419, "width": 600, "subType": "superJumbo", "crop_name": "superJumbo", "legacy": {}}, {"rank": 0, "subtype": "thumbnail", "caption": null, "credit": null, "type": "image", "url": "images/2014/06/26/business/dbpix-shire/dbpix-shire-thumbStandard.jpg", "height": 75, "width": 75, "subType": "thumbnail", "crop_name": "thumbStandard", "legacy": {"thumbnail": "images/2014/06/26/business/dbpix-shire/dbpix-shire-thumbStandard.jpg", "thumbnailwidth": 75, "thumbnailheight": 75}}, {"rank": 0, "subtype": "thumbLarge", "caption": null, "credit": null, "type": "image", "url": "images/2014/06/26/business/dbpix-shire/dbpix-shire-thumbLarge.jpg", "height": 150, "width": 150, "subType": "thumbLarge", "crop_name": "thumbLarge", "legacy": {}}], "headline": {"main": "AbbVie Signals It Will Continue to Pursue Irish Drug Maker Shire", "kicker": "DealBook", "content_kicker": null, "print_headline": "Defending Its Offer", "name": null, "seo": null, "sub": null}, "keywords": [{"name": "subject", "value": "Drugs (Pharmaceuticals)", "rank": 1, "major": "N"}, {"name": "subject", "value": "Mergers, Acquisitions and Divestitures", "rank": 2, "major": "N"}, {"name": "persons", "value": "Gonzalez, Richard", "rank": 3, "major": "N"}, {"name": "organizations", "value": "AbbVie Inc", "rank": 4, "major": "N"}, {"name": "organizations", "value": "AstraZeneca PLC", "rank": 5, "major": "N"}, {"name": "organizations", "value": "Goldman Sachs Group Inc", "rank": 6, "major": "N"}, {"name": "organizations", "value": "Pfizer Inc", "rank": 7, "major": "N"}, {"name": "organizations", "value": "Shire PLC", "rank": 8, "major": "N"}], "pub_date": "2014-06-25T13:06:34+0000", "document_type": "article", "news_desk": "Business", "section_name": "Business Day", "byline": {"original": "By David Gelles", "person": [{"firstname": "David", "middlename": null, "lastname": "Gelles", "qualifier": null, "title": null, "role": "reported", "organization": "", "rank": 1}], "organization": null}, "type_of_material": "News", "_id": "nyt://article/6f8402b9-2f2e-55f8-9167-a229e3f030ab", "word_count": 804, "uri": "nyt://article/6f8402b9-2f2e-55f8-9167-a229e3f030ab"}